More than 300 news organizations, including CBS and Forbes, quoted Abt’s Lauren Olsho explaining the benefits of our PROTECT study for the CDC, which gathers and tests nasal swabs weekly from children, regardless of whether they had COVID-19 symptoms. “Without regular weekly testing you will miss many infections, particularly for kids, who often have mild symptoms,” said Olsho, the study’s principal investigator. Other pediatric vaccine studies captured only symptomatic cases, and with more home testing, studies like Abt’s are needed for a comprehensive view of vaccine effectiveness, she noted.
Read More
COVID-19 in North America
2025 American Criminology Association Annual Meeting (ASC)
Moving at Mission Speed: How Abt’s AI Innovation Spike Delivers Practical Solutions
Abt’s AI Innovation Spike brings technologists and subject matter experts together in rapid, collaborative sprints to prototype practical, mission-aligned AI solutions.
2025 Defense Health Information Technology Symposium (DHITS)
Join Abt Global at 2025 Defense Health Information Technology Symposium (DHITS).
Advancing Military Family Health Through the Millennium Cohort Family Study
Abt Global is a key research partner to the Department Defense and Naval Health Research Center on the Millennium Cohort Family Study